AstraZeneca, european medicines agency and lung cancer
AstraZeneca, Daiichi Sankyo Withdraw Authorization Application for Lung Cancer Treatment in EU
AstraZeneca said it and Daiichi Sankyo decided to voluntarily withdraw the marketing authorization application in the European Union for advanced lung-cancer treatment Dato-DXd. This decision followed a feedback from the European Medicines Agency,
European markets are set to open higher on Tuesday, in a shortened trading session for Christmas Eve. London's FTSE 100 is ...
A once-groundbreaking sickle cell disease drug — at the center of a $5.4 billion acquisition two years ago — is the subject ...
European stocks edged higher in cautious trade on Tuesday ahead of Christmas break. The German DAX is not trading today while the ...
The Wall Street Journal on MSN8d
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing PermissionIn one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...
The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...
The biopharmaceutical company Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers seladelpar in combination with ...
12d
Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...
Celltrion secures European approval recommendation for four biosimilars Celltrion advances its global strategy with a ...
Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications.
AstraZeneca ( (GB:AZN) ) has shared an update. AstraZeneca and Daiichi Sankyo have withdrawn their EU marketing application for datopotamab deruxtecan for advanced nonsquamous non-small cell lung ...
Bristol Myers Squibb BMY announced that the European Commission has approved the combination of its blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback